ACIU 3.13 (-2.49%)
CH0329023102BiotechnologyBiotechnology

AC Immune (ACIU) Financial Metrics

This table shows a selected set of financial data points of AC Immune (ACIU). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -0.64 0 -6.59 357.14M -0.29 14.8M -61.21M -50.37M -54.23M 78.49M
2022 -0.85 0 -2.22 157.3M -0.32 3.94M -74.81M -68.42M -70.75M 31.59M
2021 -0.97 0 -4.64 338.99M -0.29 0 -68.32M -70.12M -73M 82.22M
2020 -0.86 0 -5.29 327.71M -0.23 15.43M -61.22M -59.22M -61.92M 160.89M
2019 0.64 0 12.82 582.67M 0.18 111.03M 53.34M 46.5M 45.44M 193.59M
2018 -0.82 0 -11.28 574.79M -0.31 7.19M -45.94M -49.69M -50.95M 156.46M
2017 -0.46 0 -27.07 715.12M -0.18 20.26M -23.9M -25.68M -26.41M 124.38M
2016 -0.14 0 -93.23 661.38M -0.06 23.21M -6.55M -6.56M -7.1M 152.21M
2015 0.44 0 0 0 0.37 39.09M 43.84M 20.58M 20.27M 76.52M
2014 0.19 0 0 0 0.5 30.27M -17.75M 11.05M 10.74M 3.31M
2013 0 0 0 0 0 8.64M 0 0 -11.24M 11.25M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.